• 1
    Liggins GC, Grieves SA, Kendall JZ, Knox BS. The physiological roles of progesterone, oestradiol-17 and prostaglandin F 2 in the control of ovine parturition. J Reprod Fertil Suppl 1972; 16(Suppl 16):85–10(Suppl-10).
  • 2
    Liggins GC, Fairclough RJ, Grieves SA, Kendall JZ, Knox BS. The mechanism of initiation of parturition in the ewe. Recent Prog Horm Res 1973; 29: 111159.
  • 3
    Liggins GC, Fairclough RJ, Grieves SA, Forster CS, Knox BS. Parturition in the sheep. Ciba Found Symp 1977; 47: 530.
  • 4
    Liggins GC. Initiation of parturition. Br Med Bull 1979; 35: 145150.
  • 5
    Stites DP, Siiteri PK. Steroids as immunosuppressants in pregnancy. Immunol Rev 1983; 75: 117138.
  • 6
    Gorodeski IG, Geier A, Lunenfeld B, Beery R, Bahary CM. Progesterone (P) receptor dynamics in estrogen primed normal human cervix following P injection. Fertil Steril 1987; 47: 108113.
  • 7
    Chwalisz K. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum Reprod 1994; 9 (Suppl 1): 131161.
  • 8
    Pepe GJ, Albrecht ED. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995; 16: 608648.
  • 9
    Stjernholm Y, Sahlin L, Akerberg S, Elinder A, Eriksson HA, Malmstrom A, Ekman G. Cervical ripening in humans: potential roles of estrogen, progesterone, and insulin-like growth factor-I. Am J Obstet Gynecol 1996; 174: 10651071.
  • 10
    Lydon JP, DeMayo FJ, Conneely OM, O'Malley BW. Reproductive phenotypes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 1996; 56: 6777.
  • 11
    Reynolds LP, Redmer DA. Growth and development of the corpus luteum. J Reprod Fertil Suppl 1999; 54: 181191.
  • 12
    Henson MC. Pregnancy maintenance and the regulation of placental progesterone biosynthesis in the baboon. Hum Reprod Update 1998; 4: 389405.
  • 13
    Mesiano S. Roles of estrogen and progesterone in human parturition. Front Horm Res 2001; 27: 86104.
  • 14
    Bernal AL. Overview of current research in parturition. Exp Physiol 2001; 86: 213222.
  • 15
    Young IR. The comparative physiology of parturition in mammals. In The Enodocrinology of Parturition, SmithR (ed). Reinhardt Druck: Basel, 2001; 1030.
  • 16
    Rider V. Progesterone and the control of uterine cell proliferation and differentiation. Front Biosci 2002; 7: d1545d1555.
  • 17
    Arck P, Hansen PJ, Mulac JB, Piccinni MP, Szekeres-Bartho J. Progesterone during pregnancy: endocrine-immune cross talk in Mammalian species and the role of stress. Am J Reprod Immunol 2007; 58: 268279.
  • 18
    Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG 2007; 113: 1742.
  • 19
    Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 2004; 11: 193202.
  • 20
    Fidel PI Jr, Romero R, Maymon E, Hertelendy F. Bacteria-induced or bacterial product-induced preterm parturition in mice and rabbits is preceded by a significant fall in serum progesterone concentrations. J Matern Fetal Med 1998; 7: 222226.
  • 21
    Lye SJ. The initiation and inhibition of labour: towards a molecular understanding. Semin Reprod Endocrinol 1994; 12: 284294.
  • 22
    Lye SJ, Ou CW, Tech TG, Erb G, Stevens Y, Casper R, Patel FA, Challis JRG. The molecular basis of labour and tocolysis. Fetal Maternal Med Rev 1998; 10: 121136.
  • 23
    Smith R, Mesiano S, McGrath S. Hormone trajectories leading to human birth. Regul Pept 2002; 108: 159164.
  • 24
    Smith R. Parturition. N Engl J Med 2007; 356: 271283.
  • 25
    Oh SY, Kim CJ, Park I, Romero R, Sohn YK, Moon KC, Yoon BH. Progesterone receptor isoform (A/B) ratio of human fetal membranes increases during term parturition. Am J Obstet Gynecol 2005; 193: 11561160.
  • 26
    Halmi NS. Definition of progestogens. N Engl J Med 1967; 277: 660.
  • 27
    Swyer GI, Daley D. Progesterone implantation in habitual abortion. BMJ 1953; 1: 10731077.
  • 28
    Brenner WE, Hendricks CH. Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor. Am J Obstet Gynecol 1962; 83: 10941098.
  • 29
    Levine L. Habitual abortion. A controlled study of progestational therapy. West J Surg Obstet Gynecol 1964; 72: 3036.
  • 30
    Goldzieher JW. Double-blind trial of a progestin in habitual abortion. JAMA 1964; 188: 651654.
  • 31
    Camilleri AP, Gauci NM. Progesterone depot in threatened abortion. Obstet Gynecol 1971; 38: 893895.
  • 32
    Tognoni G, Ferrario L, Inzalaco M, Crosignani PG. Progestagens in threatened abortion. Lancet 1980; 2: 12421243.
  • 33
    Varma TR, Morsman J. Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy. Int J Gynaecol Obstet 1982; 20: 1317.
  • 34
    Balasch J, Creus M, Marquez M, Burzaco I, Vanrell JA. The significance of luteal phase deficiency on fertility: a diagnostic and therapeutic approach. Hum Reprod 1986; 1: 145147.
  • 35
    Macdonald RR. Does treatment with progesterone prevent miscarriage? Br J Obstet Gynaecol 1989; 96: 257260.
  • 36
    Rand SE. Recurrent spontaneous abortion: evaluation and management. Am Fam Physician 1993; 48: 14511457.
  • 37
    Chantilis SJ, Zeitoun KM, Patel SI, Johns DA, Madziar VA, McIntire DD. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. Fertil Steril 1999; 72: 823829.
  • 38
    Oates-Whitehead RM, Haas DM, Carrier JA. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2003; CD003511.
  • 39
    Nardo LG, Sallam HN. Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles. Reprod Biomed Online 2006; 13: 4757.
  • 40
    Papiernik-Berkhauer E. Etude en double aveugle d'un medicament prevenant la survenue prematurée de l'accouchement chez des femmes ‘a risque eleve’ d'accouchement premature. Edition Schering, Serie IV, fiche 3, 1970; 6568.
  • 41
    Johnson JW, Austin KL, Jones GS, Davis GH, King TM. Efficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 1975; 293: 675680.
  • 42
    Hartikainen-Sorri AL, Kauppila A, Tuimala R. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol 1980; 56: 692695.
  • 43
    Hauth JC, Gilstrap LC, III, Brekken AL, Hauth JM. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol 1983; 146: 187190.
  • 44
    Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner BM, Kessler I, Lancet M. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 1985; 151: 574577.
  • 45
    Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 23792385.
  • 46
    da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419424.
  • 47
    da Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462469.
  • 48
    Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, Varner M, Malone F, Iams JD, Mercer BM, Thorp J, Sorokin Y, Carpenter M, Lo J, Ramin S, Harper M, Anderson G. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007; 357: 454461.
  • 49
    Daya S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. Br J Obstet Gynaecol 1989; 96: 275280.
  • 50
    Sweetman S. Martindale: The Complete Drug Reference (33rd edn). London: The Pharmaceutical Press, 2002.
  • 51
    Keirse MJ. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990; 97: 149154.
  • 52
    Goldstein P, Berrier J, Rosen S, Sacks HS, Chalmers TC. A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol 1989; 96: 265274.
  • 53
    Hendrickx AG, Korte R, Leuschner F, Neumann BW, Poggel A, Binkerd P, Prahalada S, Gunzel P. Embryotoxicity of sex steroidal hormones in nonhuman primates: II. Hydroxyprogesterone caproate, estradiol valerate. Teratology 1987; 35: 129136.
  • 54
    Greene MF. Progesterone and preterm delivery–deja vu all over again. N Engl J Med 2003; 348: 24532455.
  • 55
    Iams JD. Supplemental progesterone to prevent preterm birth. Am J Obstet Gynecol 2003; 188: 303.
  • 56
    Keirse MJ. Progesterone and preterm: seventy years of “déja vu” or “still to be seen”? Birth 2004; 31: 230235.
  • 57
    Iams JD, Newman RB, Thom EA, Goldenberg RL, Mueller-Heubach E, Moawad A, Sibai BM, Caritis SN, Miodovnik M, Paul RH, Dombrowski MP, Thurnau G, McNellis D. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med 2002; 346: 250255.
  • 58
    O'Brien JM, Adair CD, Luis DF, Hall DR, DeFranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter KVD, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007; 30: 687696.
  • 59
    Thornton JG. Progesterone and preterm labor–still no definite answers. N Engl J Med 2007; 357: 499501.
  • 60
    Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev 2006; CD004947.
  • 61
    DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007; 30: 697705.
  • 62
    Iams JD, Johnson FF, Sonek J, Sachs L, Gebauer C, Samuels P. Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol 1995; 172: 10971103.
  • 63
    Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 1996; 334: 567572.
  • 64
    Airoldi J, Berghella V, Sehdev H, Ludmir J. Transvaginal ultrasonography of the cervix to predict preterm birth in women with uterine anomalies. Obstet Gynecol 2005; 106: 553556.
  • 65
    Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Pineles BL, Gotsch F, Mittal P, Gabor TN, Espinoza J, Hassan SS. Recurrent preterm birth. Semin Perinatol 2007; 31: 142158.
  • 66
    Grimes-Dennis J, Berghella V. Cervical length and prediction of preterm delivery. Curr Opin Obstet Gynecol 2007; 19: 191195.
  • 67
    Fanchin R, De ZD, Bergeron C, Righini C, Torrisi C, Frydman R. Transvaginal administration of progesterone. Obstet Gynecol 1997; 90: 396401.
  • 68
    Kleinstein J. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction. Fertil Steril 2005; 83: 16411649.
  • 69
    Simunic V, Tomic V, Tomic J, Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertil Steril 2007; 87: 8387.
  • 70
    Geber S, Moreira AC, de Paula SO, Sampaio M. Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles. Reprod Biomed Online 2007; 14: 155158.
  • 71
    Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein MD. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. Fertil Steril 2007 Jun 15 (Epub ahead of print).
  • 72
    Hoffman HJ, Bakketeig LS. Risk factors associated with the occurrence of preterm birth. Clin Obstet Gynecol 1984; 27: 539552.
  • 73
    Roberts WE, Morrison JC, Hamer C, Wiser WL. The incidence of preterm labor and specific risk factors. Obstet Gynecol 1990; 76: 85S89S.
  • 74
    Heinonen KM, Jokela V. Multiple fetuses, growth deviations and mortality in a very preterm birth cohort. J Perinat Med 1994; 22: 511.
  • 75
    Imseis HM, Albert TA, Iams JD. Identifying twin gestations at low risk for preterm birth with a transvaginal ultrasonographic cervical measurement at 24 to 26 weeks' gestation. Am J Obstet Gynecol 1997; 177: 11491155.
  • 76
    Wennerholm UB, Holm B, Mattsby-Baltzer I, Nielsen T, Platz-Christensen J, Sundell G, Hosseini N, Hagberg H. Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet Gynaecol 1997; 104: 13981404.
  • 77
    Wright SP, Mitchell EA, Thompson JM, Clements MS, Ford RP, Stewart AW. Risk factors for preterm birth: a New Zealand study. N Z Med J 1998; 111: 1416.
  • 78
    Kiely JL. What is the population-based risk of preterm birth among twins and other multiples? Clin Obstet Gynecol 1998; 41: 311.
  • 79
    Newman RB. Obstetric management of high-order multiple pregnancies. Baillieres Clin Obstet Gynaecol 1998; 12: 109129.
  • 80
    Joseph KS, Allen AC, Dodds L, Vincer MJ, Armson BA. Causes and consequences of recent increases in preterm birth among twins. Obstet Gynecol 2001; 98: 5764.
  • 81
    Ananth CV, Demissie K, Hanley ML. Birth weight discordancy and adverse perinatal outcomes among twin gestations in the United States: the effect of placental abruption. Am J Obstet Gynecol 2003; 188: 954960.
  • 82
    Vintzileos AM, Ananth CV, Smulian JC, Scorza WE. The impact of prenatal care on preterm births among twin gestations in the United States, 1989–2000. Am J Obstet Gynecol 2003; 189: 818823.
  • 83
    Blickstein I. Do multiple gestations raise the risk of cerebral palsy? Clin Perinatol 2004; 31: 395408.
  • 84
    Elliott JP, Istwan NB, Collins A, Rhea D, Stanziano G. Indicated and non-indicated preterm delivery in twin gestations: impact on neonatal outcome and cost. J Perinatol 2005; 25: 47.
  • 85
    Ananth CV, Joseph KS, Demissie K, Vintzileos AM. Trends in twin preterm birth subtypes in the United States, 1989 through 2000: impact on perinatal mortality. Am J Obstet Gynecol 2005; 193: 10761082.
  • 86
    Friedman EA, Sachtleben MR. The effect of uterine overdistention on labor. I. Multiple pregnancy. Obstet Gynecol 1964; 23: 164172.
  • 87
    Dudley DJ. Immunoendocrinology of preterm labor: the link between corticotropin-releasing hormone and inflammation. Am J Obstet Gynecol 1999; 180: S251S256.
  • 88
    Romero R, Gomez R, Mazor M, Ghezzi F, Yoon BH. The preterm labor syndrome. In Preterm Labor, ElderMG, RomeroR, LamontRF (eds). Churchill Livingstone: New York, NY, 1997; 2949.
  • 89
    Kalkhoven E, Wissink S, Van der Saag PT, van der BB. Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor. J Biol Chem 1996; 271: 62176224.
  • 90
    Belt AR, Baldassare JJ, Molnar M, Romero R, Hertelendy F. The nuclear transcription factor NF-kappaB mediates interleukin-1beta-induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol 1999; 181: 359366.
  • 91
    Pieber D, Allport VC, Hills F, Johnson M, Bennett PR. Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod 2001; 7: 875879.
  • 92
    Pieber D, Allport VC, Bennett PR. Progesterone receptor isoform A inhibits isoform B-mediated transactivation in human amnion. Eur J Pharmacol 2001; 427: 711.
  • 93
    Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal’. Mol Hum Reprod 2001; 7: 581586.
  • 94
    Elovitz MA, Mrinalini C. The use of progestational agents for preterm birth: lessons from a mouse model. Am J Obstet Gynecol 2006; 195: 10041010.
  • 95
    Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 2007; 196: 453454.
  • 96
    Klebanoff MA. Subgroup analysis in obstetrics clinical trials. Am J Obstet Gynecol 2007; 197: 119122.
  • 97
    Carbonne B, Dallot E, Haddad B, Ferre F, Cabrol D. Effects of progesterone on prostaglandin E(2)-induced changes in glycosaminoglycan synthesis by human cervical fibroblasts in culture. Mol Hum Reprod 2000; 6: 661664.
  • 98
    Denison FC, Calder AA, Kelly RW. The action of prostaglandin E2 on the human cervix: stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor. Am J Obstet Gynecol 1999; 180: 614620.
  • 99
    Kelly RW, Leask R, Calder AA. Choriodecidual production of interleukin-8 and mechanism of parturition. Lancet 1992; 339: 776777.
  • 100
    Rajabi M, Solomon S, Poole AR. Hormonal regulation of interstitial collagenase in the uterine cervix of the pregnant guinea pig. Endocrinology 1991; 128: 863871.
  • 101
    Rodriguez HA, Kass L, Varayoud J, Ramos JG, Ortega HH, Durando M, Munoz-De-Toro M, Luque EH. Collagen remodelling in the guinea-pig uterine cervix at term is associated with a decrease in progesterone receptor expression. Mol Hum Reprod 2003; 9: 807813.
  • 102
    Sato T, Ito A, Mori Y, Yamashita K, Hayakawa T, Nagase H. Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta. Biochem J 1991; 275(Pt 3): 645650.
  • 103
    Uldbjerg N, Ekman G, Malmstrom A. Ripening of the human uterine cervix related to changes in collagen, glycosaminoglycans and collagenolytic activity. Am J Obstet Gynecol 1982; 147: 662.
  • 104
    Chwalisz K, Garfield RE. Regulation of the uterus and cervix during pregnancy and labor. Role of progesterone and nitric oxide. Ann N Y Acad Sci 1997; 828: 238253.
  • 105
    Chwalisz K, Shao-Qing S, Garfield RE, Beier HM. Cervical ripening in guinea-pigs after a local application of nitric oxide. Hum Reprod 1997; 12: 20932101.
  • 106
    Chwalisz K, Garfield R. Nitric oxide as the final metabolic mediator of cervical ripening. Hum Reprod 1998; 13: 245252.
  • 107
    Word RA, Li XH, Hnat M, Carrick K. Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. Semin Reprod Med 2007; 25: 6979.
  • 108
    Mahendroo MS, Cala KM, Russell DW. 5 alpha-reduced androgens play a key role in murine parturition. Mol Endocrinol 1996; 10: 380392.
  • 109
    Mahendroo MS, Porter A, Russell DW, Word RA. The parturition defect in steroid 5alpha-reductase type 1 knockout mice is due to impaired cervical ripening. Mol Endocrinol 1999; 13: 981992.
  • 110
    Saito Y, Takahashi S, Maki M. Effects of some drugs on ripening of uterine cervix in nonpregnant castrated and pregnant rats. Tohoku J Exp Med 1981; 133: 205220.
  • 111
    Garfield RE, Puri CP, Csapo AI. Endocrine, structural, and functional changes in the uterus during premature labor. Am J Obstet Gynecol 1982; 142: 2127.
  • 112
    Zuidema LJ, Khan-Dawood F, Dawood MY, Work BA, Jr. Hormones and cervical ripening: dehydroepiandrosterone sulfate, estradiol, estriol, and progesterone. Am J Obstet Gynecol 1986; 155: 12521254.
  • 113
    Stiemer B, Elger W. Cervical ripening of the rat in dependence on endocrine milieu; effects of antigestagens. J Perinat Med 1990; 18: 419429.
  • 114
    Ito A, Imada K, Sato T, Kubo T, Matsushima K, Mori Y. Suppression of interleukin 8 production by progesterone in rabbit uterine cervix. Biochem J 1994; 301(Pt 1): 183186.
  • 115
    Elovitz M, Wang Z. Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise. Am J Obstet Gynecol 2004; 190: 693701.
  • 116
    Marx SG, Wentz MJ, Mackay LB, Schlembach D, Maul H, Fittkow C, Given R, Vedernikov Y, Saade GR, Garfield RE. Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix. J Histochem Cytochem 2006; 54: 623639.
  • 117
    Chwalisz K, Shi Shao O, Neff G, Elger J. The effect of antigestagen ZK 98, 199 on the uterine cervix. Acta Endocrinol 1987; 283: 113.
  • 118
    Norman J. Antiprogesterones. Br J Hosp Med 1991; 45: 372375.
  • 119
    Elliott CL, Brennand JE, Calder AA. The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol 1998; 92: 804809.
  • 120
    Stenlund PM, Ekman G, Aedo AR, Bygdeman M. Induction of labor with mifepristone–a randomized, double-blind study versus placebo. Acta Obstet Gynecol Scand 1999; 78: 793798.
  • 121
    Giacalone PL, Daures JP, Faure JM, Boulot P, Hedon B, Laffargue F. The effects of mifepristone on uterine sensitivity to oxytocin and on fetal heart rate patterns. Eur J Obstet Gynecol Reprod Biol 2001; 97: 3034.
  • 122
    Hegele-Hartung C, Chwalisz K, Beier HM, Elger W. Ripening of the uterine cervix of the guinea-pig after treatment with the progesterone antagonist onapristone (ZK 98.299): an electron microscopic study. Hum Reprod 1989; 4: 369377.
  • 123
    Wolf JP, Sinosich M, Anderson TL, Ulmann A, Baulieu EE, Hodgen GD. Progesterone antagonist (RU 486) for cervical dilation, labor induction, and delivery in monkeys: effectiveness in combination with oxytocin. Am J Obstet Gynecol 1989; 160: 4547.
  • 124
    Stys SJ, Clewell WH, Meschia G. Changes in cervical compliance at parturition independent of uterine activity. Am J Obstet Gynecol 1978; 130: 414418.
  • 125
    Osmers R, Rath W, Adelmann-Grill BC, Fittkow C, Kuloczik M, Szeverényi M, Tschesche H, Kuhn W. Origin of cervical collagenase during parturition. Am J Obstet Gynecol 1992; 166: 14551460.
  • 126
    Imada K, Ito A, Sato T, Namiki M, Nagase H, Mori Y. Hormonal regulation of matrix metalloproteinase 9/gelatinase B gene expression in rabbit uterine cervical fibroblasts. Biol Reprod 1997; 56: 575580.
  • 127
    Imada K, Sato T, Hashizume K, Tanimoto A, Sasaguri Y, Ito A. An antiprogesterone, onapristone, enhances the gene expression of promatrix metalloproteinase 3/prostromelysin-1 in the uterine cervix of pregnant rabbit. Biol Pharm Bull 2002; 25: 12231227.
  • 128
    Zaragoza DB, Wilson RR, Mitchell BF, Olson DM. The interleukin 1beta-induced expression of human prostaglandin F2alpha receptor messenger RNA in human myometrial-derived ULTR cells requires the transcription factor, NFkappaB. Biol Reprod 2006; 75: 697704.
  • 129
    Vidaeff AC, Ramin SM, Gilstrap LC, III, Bishop KD, Alcorn JL. Impact of progesterone on cytokine-stimulated nuclear factor-kappaB signaling in HeLa cells. J Matern Fetal Neonatal Med 2007; 20: 2328.
  • 130
    Soloff MS, Izban MG, Cook DL, Jr, Jeng YJ, Mifflin RC. Interleukin-1-induced NF-kappaB recruitment to the oxytocin receptor gene inhibits RNA polymerase II-promoter interactions in cultured human myometrial cells. Mol Hum Reprod 2006; 12: 619624.
  • 131
    Shimizu S, Tahara M, Ogata S, Hashimoto K, Morishige K, Tasaka K, Murata Y. Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells. Mol Hum Reprod 2007; 13: 181187.
  • 132
    Mendelson CR, Condon JC. New insights into the molecular endocrinology of parturition. J Steroid Biochem Mol Biol 2005; 93: 113119.
  • 133
    Lee Y, Allport V, Sykes A, Lindstrom T, Slater D, Bennett P. The effects of labour and of interleukin 1 beta upon the expression of nuclear factor kappa B related proteins in human amnion. Mol Hum Reprod 2003; 9: 213218.
  • 134
    Duggan SV, Lindstrom T, Iglesias T, Bennett PR, Mann GE, Bartlett SR. Role of atypical protein kinase C isozymes and NF-kappaB in IL-1beta-induced expression of cyclooxygenase-2 in human myometrial smooth muscle cells. J Cell Physiol 2007; 210: 637643.
  • 135
    Choi SJ, Oh S, Kim JH, Roh CR. Changes of nuclear factor kappa B (NF-kappaB), cyclooxygenase-2 (COX-2) and matrix metalloproteinase-9 (MMP-9) in human myometrium before and during term labor. Eur J Obstet Gynecol Reprod Biol 2007; 132: 182188.
  • 136
    Lappas M, Yee K, Permezel M, Rice GE. Lipopolysaccharide and TNF-alpha activate the nuclear factor kappa B pathway in the human placental JEG-3 cells. Placenta 2006; 27: 568575.
  • 137
    Schmitz T, Souil E, Herve R, Nicco C, Batteux F, Germain G, Cabrol D, Evain-Brion D, Leroy MJ, Mehats C. PDE4 inhibition prevents preterm delivery induced by an intrauterine inflammation. J Immunol 2007; 178: 11151121.
  • 138
    Bukowski R, Hankins GD, Saade GR, Anderson GD, Thornton S. Labor-associated gene expression in the human uterine fundus, lower segment, and cervix. PLoS Med 2006; 3: e169.
  • 139
    Bennett P, Allport V, Loudon J, Elliott C. Prostaglandins, the fetal membranes and the cervix. Front Horm Res 2001; 27: 147164.
  • 140
    Condon JC, Hardy DB, Kovaric K, Mendelson CR. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Mol Endocrinol 2006; 20: 764775.
  • 141
    Hardy DB, Janowski BA, Corey DR, Mendelson CR. Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. Mol Endocrinol 2006; 20: 27242733.
  • 142
    Henderson D, Wilson T. Reduced binding of progesterone receptor to its nuclear response element after human labor onset. Am J Obstet Gynecol 2001; 185: 579585.
  • 143
    Allan GF, Tsai SY, Tsai MJ, O'Malley BW. Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding. Proc Natl Acad Sci USA 1992; 89: 1175011754.
  • 144
    Beato M. Gene regulation by steroid hormones. Cell 1989; 56: 335344.
  • 145
    Brosens JJ, Tullet J, Varshochi R, Lam EW. Steroid receptor action. Best Pract Res Clin Obstet Gynaecol 2004; 18: 265283.
  • 146
    Merlino AA, Welsh TN, Tan H, Yi LJ, Cannon V, Mercer BM, Mesiano S. Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A. J Clin Endocrinol Metab 2007; 92: 19271933.
  • 147
    Power RF, Conneely OM, O'Malley BW. New insights into activation of the steroid hormone receptor superfamily. Trends Pharmacol Sci 1992; 13: 318323.
  • 148
    Rodriguez R, Carson MA, Weigel NL, O'Malley BW, Schrader WT. Hormone-induced changes in the in vitro DNA-binding activity of the chicken progesterone receptor. Mol Endocrinol 1989; 3: 356362.
  • 149
    Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994; 63: 451486.
  • 150
    Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 1993; 7: 12441255.
  • 151
    Denner LA, Weigel NL, Maxwell BL, Schrader WT, O'Malley BW. Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 1990; 250: 17401743.
  • 152
    Meizel S, Turner KO. Progesterone acts at the plasma membrane of human sperm. Mol Cell Endocrinol 1991; 77: R1R5.
  • 153
    Meizel S, Turner KO, Nuccitelli R. Progesterone triggers a wave of increased free calcium during the human sperm acrosome reaction. Dev Biol 1997; 182: 6775.
  • 154
    Turner KO, Garcia MA, Meizel S. Progesterone initiation of the human sperm acrosome reaction: the obligatory increase in intracellular calcium is independent of the chloride requirement. Mol Cell Endocrinol 1994; 101: 221225.
  • 155
    Tian J, Kim S, Heilig E, Ruderman JV. Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation. Proc Natl Acad Sci USA 2000; 97: 1435814363.
  • 156
    McEwen BS. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991; 12: 141147.
  • 157
    Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci 1990; 13: 359362.
  • 158
    Fomin VP, Cox BE, Word RA. Effect of progesterone on intracellular Ca2 + homeostasis in human myometrial smooth muscle cells. Am J Physiol 1999; 276: C379C385.
  • 159
    Perusquia M, Garcia-Yanez E, Ibanez R, Kubli-Garfias C. Non-genomic mechanism of action of delta-4 and 5-reduced androgens and progestins on the contractility of the isolated rat myometrium. Life Sci 1990; 47: 15471553.
  • 160
    Kofinas AD, Rose JC, Koritnik DR, Meis PJ. Progesterone and estradiol concentrations in nonpregnant and pregnant human myometrium. Effect of progesterone and estradiol on cyclic adenosine monophosphate-phosphodiesterase activity. J Reprod Med 1990; 35: 10451050.
  • 161
    Sager G, Orbo A, Jaeger R, Engstrom C. Non-genomic effects of progestins–inhibition of cell growth and increased intracellular levels of cyclic nucleotides. J Steroid Biochem Mol Biol 2003; 84: 18.
  • 162
    Sfakianaki AK, Norwitz ER. Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med 2006; 19: 763772.
  • 163
    Blackmore PF, Neulen J, Lattanzio F, Beebe SJ. Cell surface-binding sites for progesterone mediate calcium uptake in human sperm. J Biol Chem 1991; 266: 1865518659.
  • 164
    Chapman NR, Kennelly MM, Harper KA, Europe-Finner GN, Robson SC. Examining the spatiotemporal expression of mRNA encoding the membrane-bound progesterone receptor-alpha isoform in human cervix and myometrium during pregnancy and labour. Mol Hum Reprod 2006; 12: 1924.
  • 165
    Falkenstein E, Meyer C, Eisen C, Scriba PC, Wehling M. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun 1996; 229: 8689.
  • 166
    Falkenstein E, Heck M, Gerdes D, Grube D, Christ M, Weigel M, Buddhikot M, Meizel S, Wehling M. Specific progesterone binding to a membrane protein and related nongenomic effects on Ca2 + -fluxes in sperm. Endocrinology 1999; 140: 59996002.
  • 167
    Falkenstein E, Norman AW, Wehling M. Mannheim classification of nongenomically initiated (rapid) steroid action(s). J Clin Endocrinol Metab 2000; 85: 20722075.
  • 168
    Foresta C, Rossato M, Di VF. Ion fluxes through the progesterone-activated channel of the sperm plasma membrane. Biochem J 1993; 294(Pt 1): 279283.
  • 169
    Losel R, Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 2003; 4: 4656.
  • 170
    Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K, Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 2003; 83: 9651016.
  • 171
    Luconi M, Bonaccorsi L, Maggi M, Pecchioli P, Krausz C, Forti G, Baldi E. Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane. J Clin Endocrinol Metab 1998; 83: 877885.
  • 172
    Meyer C, Schmid R, Scriba PC, Wehling M. Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem 1996; 239: 726731.
  • 173
    Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 2003; 100: 22372242.
  • 174
    Zhu Y, Rice CD, Pang Y, Pace M, Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 2003; 100: 22312236.
  • 175
    Modi CN, Shah C, Puri CP. Non-genomic membrane progesterone receptors on human spermatozoa. Soc Reprod Fertil 2007; 63 (Suppl): 515529. Review.
  • 176
    Fernandes MS, Pierron V, Michalovich D, Astle S, Thornton S, Peltoketo H, Lam EW, Gellersen B, Huhtaniemi I, Allen J, Brosens JJ. Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues. J Endocrinol 2005; 187: 89101.
  • 177
    Grazzini E, Guillon G, Mouillac B, Zingg HH. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 1998; 392: 509512.
  • 178
    Haukkamaa M. High affinity progesterone binding sites of human uterine microsomal membranes. J Steroid Biochem 1984; 20: 569573.
  • 179
    Karteris E, Zervou S, Pang Y, Dong J, Hillhouse EW, Randeva HS, Thomas P. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 2006; 20: 15191534.
  • 180
    Mesiano S. Myometrial progesterone responsiveness. Semin Reprod Med 2007; 25: 513.
  • 181
    Romero R, Scoccia B, Mazor M, Wu YK, Benveniste R. Evidence for a local change in the progesterone/estrogen ratio in human parturition at term. Am J Obstet Gynecol 1988; 159: 657660.
  • 182
    Cicinelli E, de Ziegler D. Transvaginal progesterone: evidence for a new functional ‘portal system’ flowing from the vagina to the uterus. Hum Reprod Update 1999; 5: 365372.
  • 183
    Andersen HF, Nugent CE, Wanty SD, Hayashi RH. Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1990; 163: 859867.
  • 184
    Taipale P, Hiilesmaa V. Sonographic measurement of uterine cervix at 18–22 weeks' gestation and the risk of preterm delivery. Obstet Gynecol 1998; 92: 902907.
  • 185
    Heath VC, Southall TR, Souka AP, Elisseou A, Nicolaides KH. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 1998; 12: 312317.
  • 186
    Hassan SS, Romero R, Berry SM, Dang K, Blackwell SC, Treadwell MC, Wolfe HM. Patients with an ultrasonographic cervical length < or = 15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 2000; 182: 14581467.
  • 187
    Tekesin I, Eberhart LH, Schaefer V, Wallwiener D, Schmidt S. Evaluation and validation of a new risk score (CLEOPATRA score) to predict the probability of premature delivery for patients with threatened preterm labor. Ultrasound Obstet Gynecol 2005; 26: 699706.
  • 188
    To MS, Skentou CA, Royston P, Yu CK, Nicolaides KH. Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol 2006; 27: 362367.
  • 189
    Heath VC, Daskalakis G, Zagaliki A, Carvalho M, Nicolaides KH. Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery. BJOG 2000; 107: 12761281.
  • 190
    To MS, Palaniappan V, Skentou C, Gibb D, Nicolaides KH. Elective cerclage vs. ultrasound-indicated cerclage in high-risk pregnancies. Ultrasound Obstet Gynecol 2002; 19: 475477.
  • 191
    To MS, Alfirevic Z, Heath VC, Cicero S, Cacho AM, Williamson PR, Nicolaides KH. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 2004; 363: 18491853.
  • 192
    Palma-Dias RS, Fonseca MM, Stein NR, Schmidt AP, Magalhaes JA. Relation of cervical length at 22–24 weeks of gestation to demographic characteristics and obstetric history. Braz J Med Biol Res 2004; 37: 737744.
  • 193
    Gomez R, Romero R, Nien JK, Chaiworapongsa T, Medina L, Kim YM, Yoon BH, Carstens M, Espinoza J, Iams JD, Gonzalez R. A short cervix in women with preterm labor and intact membranes: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol 2005; 192: 678689.
  • 194
    Gomez R, Romero R, Medina L, Nien JK, Chaiworapongsa T, Carstens M, Gonzalez R, Espinoza J, Iams JD, Edwin S, Rojas I. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol 2005; 192: 350359.
  • 195
    Hassan S, Romero R, Hendler I, Gomez R, Khalek N, Espinoza J, Nien JK, Berry SM, Bujold E, Camacho N, Sorokin Y. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 2006; 34: 1319.
  • 196
    Alfirevic Z, len-Coward H, Molina F, Vinuesa CP, Nicolaides K. Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial. Ultrasound Obstet Gynecol 2007; 29: 4750.
  • 197
    Kusanovic JP, Espinoza J, Romero R, Goncalves L, Nien JK, Soto E, Khalek N, Camacho N, Hendler I, Mittal P, Friel LA, Gotsch F, Erez O, Than NG, Mazaki-Tovi S, Schoen ML, Hassan S. Clinical significance of the presence of amniotic fluid ‘sludge’ in asymptomatic patients at high risk for spontaneous preterm delivery. Ultrasound Obstet Gynecol 2007; 30: 706714.
  • 198
    Owen J, Yost N, Berghella V, Thom E, Swain M, Dildy GA, III, Miodovnik M, Langer O, Sibai B, McNellis D. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 2001; 286: 13401348.
  • 199
    Althuisius S, Dekker G, Hummel P, Bekedam D, Kuik D, van GH. Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): effect of therapeutic cerclage with bed rest vs. bed rest only on cervical length. Ultrasound Obstet Gynecol 2002; 20: 163167.
  • 200
    Althuisius SM, Dekker GA, Hummel P, van Geijn HP. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2003; 189: 907910.
  • 201
    Romero R, Avila C, Brekus CA, Morotti R. The role of systemic and intrauterine infection in preterm parturition. Ann N Y Acad Sci 1991; 622: 355375.
  • 202
    Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer DM. The preterm labor syndrome. Ann N Y Acad Sci 1994; 734: 414429.
  • 203
    Romero R, Espinoza J, Mazor M, Chaiworapongsa T. The preterm parturition syndrome. In Preterm Birth, CritchelyH, BennettP, ThorntonS (eds). RCOG Press: London, 2004; 2860.
  • 204
    Romero R, Avila C, Sepulveda W. The role of systemic and intrauterine infection in preterm labor. In Preterm Birth: Causes, Prevention, and Management, FuchsA, FuchsF, StubblefieldP (eds). McGraw-Hill: New York, 1993.
  • 205
    Romero R, Espinoza J, Erez O, Hassan S. The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified? Am J Obstet Gynecol 2006; 194: 19.
  • 206
    Romero R. The child is the father of the man. Prenat Neonat Med 1996; 1: 811.
  • 207
    Moinian M, Andersch B. Does cervix conization increase the risk of complications in subsequent pregnancies? Acta Obstet Gynecol Scand 1982; 61: 101103.
  • 208
    Kristensen J, Langhoff-Roos J, Wittrup M, Bock JE. Cervical conization and preterm delivery/low birth weight. A systematic review of the literature. Acta Obstet Gynecol Scand 1993; 72: 640644.
  • 209
    Raio L, Ghezzi F, Di NE, Gomez R, Luscher KP. Duration of pregnancy after carbon dioxide laser conization of the cervix: influence of cone height. Obstet Gynecol 1997; 90: 978982.
  • 210
    Craig CJ. Congenital abnormalities of the uterus and foetal wastage. S Afr Med J 1973; 47: 20002005.
  • 211
    Mangan CE, Borow L, Burtnett-Rubin MM, Egan V, Giuntoli RL, Mikuta JJ. Pregnancy outcome in 98 women exposed to diethylstilbestrol in utero, their mothers, and unexposed siblings. Obstet Gynecol 1982; 59: 315319.
  • 212
    Ludmir J, Landon MB, Gabbe SG, Samuels P, Mennuti MT. Management of the diethylstilbestrol-exposed pregnant patient: a prospective study. Am J Obstet Gynecol 1987; 157: 665669.
  • 213
    Levine RU, Berkowitz KM. Conservative management and pregnancy outcome in diethylstilbestrol-exposed women with and without gross genital tract abnormalities. Am J Obstet Gynecol 1993; 169: 11251129.
  • 214
    Romero R, Gonzalez R, Sepulveda W, Brandt F, Ramirez M, Sorokin Y, Mazor M, Treadwell MC, Cotton DB. Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol 1992; 167: 10861091.
  • 215
    Mays JK, Figueroa R, Shah J, Khakoo H, Kaminsky S, Tejani N. Amniocentesis for selection before rescue cerclage. Obstet Gynecol 2000; 95: 652655.
  • 216
    Bengtsson LP. Cervical insufficiency. Acta Obstet Gynecol Scand 1968; 47(Suppl 1): 735.
  • 217
    Sherman AI. Hormonal therapy for control of the incompetent os of pregnancy. Obstet Gynecol 1966; 28: 198205.
  • 218
    Christian MS, Brent RL, Calda P. Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins. J Matern Fetal Neonatal Med 2007; 20: 89112.
  • 219
    Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Meis PJ, Das A, McNellis D, Miodovnik M, Menard MK, Caritis SN, Thurnau GR, Bottoms SF. The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1997; 177: 812.
  • 220
    Sakai M, Shiozaki A, Tabata M, Sasaki Y, Yoneda S, Arai T, Kato K, Yamakawa Y, Saito S. Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 in cervical mucus. Am J Obstet Gynecol 2006; 194: 1419.
  • 221
    Garfield RE, Maul H, Maner W, Fittkow C, Olson G, Shi L, Saade G. Uterine electromyography and light-induced fluorescence in the management of term and preterm labor. J Soc Gynecol Inv 2002; 9: 265275.
  • 222
    Garfield RE, Maul H, Shi L, Maner W, Fittkow C, Olsen G, Saade GR. Methods and devices for the management of term and preterm labor. Ann N Y Acad Sci 2001; 943: 203224.
  • 223
    Fittkow CT, Maul H, Olson G, Martin E, Mackay LB, Saade GR, Garfield RE. Light-induced fluorescence of the human cervix decreases after prostaglandin application for induction of labor at term. Eur J Obstet Gynecol Reprod Biol 2005; 123: 6266.
  • 224
    Maul H, Mackay LB, Garfield RE. Cervical ripening: biochemical, molecular, and clinical considerations. Clin Obstet Gynecol 2006; 49: 551563.
  • 225
    Robert JA, Romero R, Costigan K. Amniotic fluid concentrations of fibronectin and intra-amniotic infection. Am J Perinatol 1988; 5: 2628.
  • 226
    Romero R, Jimenez C, Lohda AK, Nores J, Hanaoka S, Avila C, Callahan R, Mazor M, Hobbins JC, Diamond MP. Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol 1990; 163: 968974.
  • 227
    Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990; 85: 13921400.
  • 228
    Romero R, Quintero R, Nores J, Avila C, Mazor M, Hanaoka S, Hagay Z, Merchant L, Hobbins JC. Amniotic fluid white blood cell count: a rapid and simple test to diagnose microbial invasion of the amniotic cavity and predict preterm delivery. Am J Obstet Gynecol 1991; 165: 821830.
  • 229
    Gomez R, Romero R, Galasso M, Behnke E, Insunza A, Cotton DB. The value of amniotic fluid interleukin-6, white blood cell count, and gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term. Am J Reprod Immunol 1994; 32: 200210.
  • 230
    Maymon E, Romero R, Chaiworapongsa T, Berman S, Conoscenti G, Gomez R, Edwin S. Amniotic fluid matrix metalloproteinase-8 in preterm labor with intact membranes. Am J Obstet Gynecol 2001; 185: 11491155.
  • 231
    Yoon BH, Romero R, Lim JH, Shim SS, Hong JS, Shim JY, Jun JK. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003; 189: 919924.
  • 232
    Nien JK, Yoon BH, Espinoza J, Kusanovic JP, Erez O, Soto E, Richani K, Gomez R, Hassan S, Mazor M, Edwin S, Bahado-Singh R, Romero R. A rapid MMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery. Am J Obstet Gynecol 2006; 195: 10251030.
  • 233
    Gomez R, Romero R, Nien JK, Medina L, Carstens M, Kim YM, Espinoza J, Chaiworapongsa T, Gonzalez R, Iams JD, Rojas I. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med 2007; 20: 167173.
  • 234
    Espinoza J, Goncalves L, Romero R, Nien JK, Stites S, Kim YM, Hassan S, Gomez R, Yoon BH, Chaiworapongsa T, Lee W, Mazor M. The prevalence and clinical significance of amniotic fluid ‘sludge’ in patients with preterm labor and intact membranes. Ultrasound Obstet Gynecol 2005; 25: 346352.
  • 235
    Romano A, Delvoux B, Fischer DC, Groothuis P. The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone. J Mol Endocrinol 2007; 38: 331350.
  • 236
    Cramer DW, Hornstein MD, McShane P, Powers RD, Lescault PJ, Vitonis AF, De Vivo I. Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization. Am J Obstet Gynecol 2003; 189: 10851092.
  • 237
    Marshburn PB, Zhang J, Bahrani-Mostafavi Z, Matthews ML, White J, Hurst BS. Variant progesterone receptor mRNAs are co-expressed with the wild-type progesterone receptor mRNA in human endometrium during all phases of the menstrual cycle. Mol Hum Reprod 2005; 11: 809815.